Objective: To evaluate serum concentrations of trace elements in tuberculosis (TB) patients with or with out human immunodeficiency virus (HIV) coinfection before and after anti-TB chemotherapy. Subjects: A total of 155 TB patients, 74 of which were coinfected with HIV, and 31 healthy controls from Gondar, Ethiopia. Methods: Serum levels of copper, zinc, selenium and iron were determined using an inductively coupled plasma mass spectrometer from all subjects at baseline and from 44 TB patients (22 with HIV coinfection) at the end of an intensive phase of anti-TB chemotherapy. Results: Compared with the control group, the concentrations of iron, zinc and selenium were significantly lower (Po0.05) while that of copper and copper/zinc ratio was significantly higher (Po0.05) in the serum of TB patients. TB patients with HIV coinfection had significantly lower serum zinc and selenium concentrations and significantly higher copper/zinc ratio compared to that in TB patients without HIV coinfection (Po0.05). The serum concentration of zinc had significantly increased at the end of intensive phase of anti-TB chemotherapy in patients without HIV coinfection (Po0.05). An increase in serum selenium level was observed in TB patients with or without HIV coinfection after therapy. On the contrary, serum copper concentration and copper/zinc ratio declined significantly after anti-TB chemotherapy irrespective of HIV serostatus (Po0.05).
Introduction
Approximately one-third of the world's human population is infected with Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB). Coupled with the pandemic of human immunodeficiency virus (HIV), TB is an important cause of morbidity and mortality worldwide (Corbett et al., 2003) . The World Health Organization (WHO) estimates that as of the end of 2003 there were over 40 million people living with HIV/AIDS in the world (UNAIDS/ WHO, 2003) and about a third of these are also coinfected with M. tuberculosis (WHO, 2003) . Among the people who are dually infected with M. tuberculosis and HIV, more than 70% live in subSaharan Africa, a region with the highest TB incidence rate (290 per 100 000 population) (Corbett et al., 2003) . In Ethiopia too, TB and HIV/AIDS are among the leading causes of outpatient morbidity, hospital admission and death (Ministry of Health, 2002a, b) .
It has been known for many years that nutritional deficiencies can lead to increased susceptibility to infectious diseases (Scrimshaw, 1975) . TB and HIV infection frequently occur together and can result in severe wasting (Niyongabo et al., 1999a; Lettow van et al., 2004) . The wasting, in turn, affects the inflammatory response, suppresses cellular immunity, and aggravates the severity and outcome of disease (Shears, 1991) . In these complex interactions among TB, HIV infection and the host immune response, trace elements play important roles (Failla, 2003) . Although variation in the concentrations of essential trace elements was reported in several pathological conditions (Beck et al., 1990; Graham et al., 1991; Rosas et al., 1995; Hua-Dong et al., 1999; Karyadi et al., 2000; Karakas et al., 2001; Kuo et al., 2002; Ciftci et al., 2003; Hamed et al., 2004; Meram et al., 2004) , their levels in sera of TB patients with HIV coinfection and their changes in concentration after therapy is not yet well documented. This study was, therefore, aimed at comparing serum levels of iron, copper, zinc, and selenium from TB patients with and without HIV coinfection with those of healthy subjects, and also to investigate changes in their serum concentrations before and after an intensive phase of anti-TB chemotherapy.
Patients and methods
Study subjects, diagnosis and treatment of TB Consecutive TB patients attending hospital of the University of Gondar in Ethiopia with a diagnosis of TB were enrolled. As controls, apparently healthy volunteers with no previous history of TB, and who were living in the same geographic locale with TB patients, were recruited. The University teaching hospital is a major tertiary level referral hospital rendering health services for over 4 million inhabitants in the Northwest Ethiopia. The study proposal was approved by the research ethics committees of the University of Gondar, Gondar, Ethiopia and the University of Tokushima, Tokushima, Japan. Informed consent was obtained from all patients. TB was diagnosed by medical doctors as described previously (Kassu et al., 2004) . To be considered as a case of TB, an individual had to have two or more of the following: (1) positive sputum smear, (2) histopathological evidence, (3) radiographic examination consistent with TB and (4) clinical response to anti-TB chemotherapy. After TB diagnosis, all patients received directly observed therapy short course (DOTS) as per the protocol of the National Tuberculosis and Leprosy Prevention and Control Programme (Ministry of Health, 2002b) . All HIV-infected TB patients were naïve to antiretroviral drugs as antiretroviral therapy was not in use in the country during the study period.
Nutritional assessment
Body weight was determined to the nearest 0.1 kg on an electronic digital scale and height was measured to the nearest 0.1 cm. Body mass index (BMI), defined as the weight in kilogram of the individual divided by the square of the height in metre, was used to determine the nutritional status of the patients into severe malnutrition (BMIo15.9 kg/m Blood collection, serum separation and HIV serology Whole blood was collected from TB patients prior to initiation of anti-TB treatment and healthy controls. Subsamples of the TB patients were followed up during therapy and blood samples were collected again at the end of intensive phase of anti-TB chemotherapy. Serum was separated by centrifugation within 2 h of collection and kept at À201C until used. The presence of HIV antibodies was determined by an enzyme-linked immunosorbent assay following the manufacturer's instruction (Vironostica HIV Uni-Form II plus O, Organon Teknika, Boxtel, the Netherlands).
Determination of trace elements in serum
The frozen serum samples were kept on dry ice and air freighted to Japan. Concentration of trace elements in serum was determined using an inductively coupled plasma mass spectrometer (ICP-MS) (model 8500, Schimadzu, Tokyo, Japan), at Department of Analytical Chemistry, the University of Tokushima, Japan (Hasegawa et al., 2001) . In brief, serum sample (200 ml) was aliquoted in to teflon tube and covered with teflon ball. After adding 1 ml of concentrated HNO3 (Wako Pure Chemicals, Japan), the tube was heated on an aluminum heating block (IWAKI, Asahi Techno Glass, Japan) at 1201C for 5 h. The sample was further heated almost to dryness at 2001C after removing the teflon ball. Finally, the residue was dissolved with 2 ml of 0.1 M HNO 3 which contained 10 ng/ml internal standard elements (In, Re and Tl). The diluted serum solution was used for analysis of the elements in ICP-MS. Commercially available singleelement standard solutions (1000 mg/ml) were purchased from Wako Pure Chemicals (Osaka, Japan) and used for standardization of calibration curves.
Statistical analysis
Data were analysed using SPSS version 10 statistical package (SPSS Inc., Chicago, IL, USA). A one-sample KolmogorovSmirnov test was used to assess whether the data were normally distributed. Only serum iron values were nonnormally distributed and hence log transformed. Comparisons of serum values of the trace elements among TB patients with and without HIV coinfection and control groups were made using a one-way analysis of variance. Post hoc Tukey test was used to determine which pairs of means differ significantly. The paired T-test was used to compare pretreatment and post-treatment data. Logistic regression analysis was employed to determine factors related to deficiency of trace elements. Deficiency of zinc, selenium, copper and iron were defined at their serum levels less than 75, 7, 75 and 60 mg/dl, respectively (Sauberlich, 1999) . Pvalues less than 0.05 were considered statistically significant.
Results
A total of 155 TB patients (81 HIV seronegative and 74 HIV seropositive) and 31 healthy controls were included in the study. Table 1 shows demographic, nutritional and clinical status of the patients and controls. Malnutrition (BMIo18.5 kg/m 2 ) was detected in 71.6% of HIV-positive and 65.4% of HIV-negative TB patients. Severe malnutrition (BMIo15.9 kg/m 2 ) was more pronounced in TB patients with HIV coinfection. Majority of the patients manifested cough, weight loss, fever and night sweats irrespective of HIV serostatus. Extrapulmonary TB was diagnosed in greater proportion of TB patients with HIV coinfection. Low levels of trace elements were observed in serum of most TB patients (Table 1) . Table 2 shows the concentrations of serum zinc, copper, selenium and iron in TB patients and healthy controls. The mean7s.d. concentration of zinc in sera of TB patients coinfected with HIV was significantly lower (Po0.05) than that in TB patients without HIV coinfection and healthy controls. Likewise, its level in TB patients without HIV coinfection was significantly lower than that in healthy controls (Po0.05). On the other hand, the mean7s.d. serum copper concentration was significantly higher in TB patients with or without HIV coinfection compared to healthy controls, Po0.001. As a result the ratio of copper to zinc concentration in serum was significantly higher in TB patients coinfected with HIV compared to TB patients without HIV coinfection (Po0.05) and healthy controls (Po0.01). The ratio was also significantly higher in TB patients with HIV coinfection than in healthy controls, Po0.01. The serum concentration of selenium was significantly lower in TB patients with HIV coinfection compared to TB patients without HIV coinfection (Po0.05) and healthy controls (Po0.01). In addition, the serum level of selenium in TB patients without HIV coinfection was significantly lower than that in healthy controls, Po0.05. Serum iron concentration was significantly higher in healthy controls than in TB patients with HIV coinfection (Po0.01). Although the serum iron concentration was remarkably lower in TB patients without HIV coinfection compared to its level in healthy controls, the difference was not statistically significant (P ¼ 0.07).
Regression analyses of age, sex, BMI and clinical signs of TB as independent variables and serum level of micronutrients as dependent variables did not show any significant association except that of female sex to serum iron in TB patients with HIV coinfection (OR, 95% CI ¼ 0.1, 0.01-0.97, Po0.05). On the other hand, no significant difference was observed in the concentration of trace elements between patients with pulmonary TB and EPTB. Sauberlich (1999) .
Trace elements in tuberculosis and HIV infections A Kassu et al
As summarized in Table 2 , in 44 TB patients (22 HIV seronegative and 22 HIV seropositive), effect of anti-TB chemotherapy on the profile of trace elements concentration in serum was studied by comparing their level at baseline and at the end of intensive phase of anti-TB chemotherapy. The concentration of copper in serum had significantly declined 2 months after anti-TB chemotherapy compared to its pretreatment serum concentration both in HIV seronegative and seropositive TB patients, Po0.05. On the other hand, the level of Zn in TB patients without HIV coinfection increased significantly after therapy (Po0.05), while this was not the case in TB patients coinfected with HIV. The Cu/Zn ratio had significantly declined after therapy in TB patients with or without HIV coinfection, Po0.05. The change in concentration of selenium and iron was not significantly different, although an increase was noted for serum selenium levels in both groups.
Discussion
In the present study it was demonstrated that TB patients had low serum concentrations of iron, zinc and selenium and high level of copper and copper/zinc ratio when compared to healthy controls. The alteration was more pronounced in TB patients coinfected with HIV.
The low zinc concentrations in serum observed in adult Ethiopian TB patients was in agreement with the reports from India (Ahmad et al., 1985) , Indonesia (Karyadi et al., 2000) , Turkey (Ciftci et al., 2003) and Ecuador (Koyanagi et al., 2004) . The decline was probably due to redistribution of zinc from serum to other tissues (Cousins and Leinart, 1988) or reduction of zinc-carrier proteins and or a rise in the production of metallothionein, a protein that transports zinc to the liver (Gabay and Kushner, 1999) . It is worth noting that the level of zinc in patients coinfected with HIV was also very low indicating strong association of hypozincaemia with impaired immune response and degree of malnutrition as reported previously from HIV-seropositive and AIDS patients (Graham et al., 1991) . Zinc deficiency was shown to decrease the production of tumour necrosis factor-a (TNFa) and gamma interferon (IFN-g) from peripheral mononuclear cells (Beck et al., 1997) . It was also suggested that administration of anti-TNF-a to patients may lead to reactivation of TB (Mayordomo et al., 2002) , and a mutation in the gene coding for the IFN-g receptor resulted in an increased susceptibility to mycobacterial infections (Newport et al., 1996) . It therefore seems possible that zinc deficiency is implicated in the activation of TB. It is interesting to note that supplementation of zinc (Pant et al., 1987) or zinc and vitamin-A (Karyadi et al., 2002) to adult TB patients resulted in faster clearance of acid fast bacilli from sputum and faster resolution of chest-X-ray pathology.
The high serum copper concentrations observed in the TB patients were also in line with previous reports (Bogden et al., 1977; Ahmad et al., 1985; Ciftci et al., 2003; Koyanagi et al., 2004) . The elevated serum levels of copper may reflect a nonspecific increase in serum concentration of copperbinding protein, ceruloplasmin (Beisel, 1976) . Plasma concentrations of ceruloplasmin and copper increase as an acute-phase response in a variety of infections and inflammatory conditions (Bogden et al., 2000) . High serum levels of copper were also reported in HIV-infected patients suggesting its possible role as a useful marker of HIV activity and progression to AIDS (Moreno et al., 1998; Bogden et al., 2000) .
The concentration of copper and zinc in the serum of healthy humans has been reported to be proportional to each other but vary during infections (Falchuk, 1998) . Determination of the ratio of copper/zinc has been considered helpful in diagnosing many diseases, observing their transformations, and in reflecting the nutritional status of zinc in human body better than its content in serum (Hua-Dong et al., 1999) . It was also suggested that if the ratio of copper/zinc exceeds 2, it would indicate severity of the infection (Hua-Dong et al., 1999) . Elevated copper/zinc ratio was reported in patients with different pathological conditions such as intestinal amebiasis and giardiasis (Karakas et al., 2001) , lymphoma and leukemias (Rosas et al., 1995) , gastric cancer (Hua-Dong et al., 1999) , and breast cancer (Kuo et al., 2002) and considered to have diagnostic and prognostic values. In the present study too, the ratio of copper/zinc was higher in serum of TB patients with and without HIV coinfection compared to that in healthy subjects.
Low serum iron concentration is not uncommon in TB patients (Kaminskaia and Abdullaev, 2002) . In line with these, the concentration of serum iron in TB patients was low in the present study. In a study conducted in Ghana, 50 adults with pulmonary TB had significantly lower haemoglobin than healthy matched controls (Lawn et al., 2000) . In Uganda, mean haemoglobin concentrations were lower among HIV-infected adults with TB than in HIV-infected adults without TB (Shah et al., 2001) . Low plasma transferrin concentrations have been described among HIV-infected adults with TB (Niyongabo et al., 1999b) . There are two explanations for the association of low iron status with infection. One is that anaemia results from chronic inflammation. In line with this, Monteiro et al. (2000) suggested the implication of acute-phase response on the etiology of anaemia in HIV-positive patients by demonstrating higher serum ferritin levels among APR-positive subjects compared to those which are negative for acute-phase response (568 (45.3-1814) versus 246 (18.4-1577) ng/ml, Po0.05). This might indicate that the hypoferraemia in TB patients with or without HIV coinfection may be induced by the shift of iron from a transferrin-bound available state to a ferritinincorporated storage state. The condition may have evolved as a cytokine-mediated defense against microbial pathogens, effectively withholding iron from microbes, which incidentally also deprives erythroid precursors of their iron supply (Jurado, 1997) . The other, which is more speculative, is that iron deficiency would increase susceptibility to an infection such as TB. In this context, it may be argued that cellmediated immunity is compromised in iron deficiency (Dallman, 1987) before anaemia becomes apparent. It is worth mentioning that subjects with HIV infection manifest iron deficiency, which may be ascribed to intestinal malabsorption (Castaldo et al., 1996) .
Like zinc and iron, a significantly low level of serum selenium was observed in TB patients. Selenium is known to be an essential component of antioxidative selenoenzymes such as glutathione peroxidase which are known to protect host cells from oxidative damage in inflammatory conditions (McKenzie et al., 1998) . Although the mechanisms involved have yet to be elucidated, the important role of selenium in normal immune responses is well established (McKenzie et al., 1998) . Selenium also has immunopotentiating effects as its deficiency appears to result in immunosuppression, whereas supplementation with low doses of selenium appears to result in augmentation and/or restoration of immunologic functions (Roy et al., 1994) . An inverse correlation between this micronutrient and HIV infection has been reported (Dworkin, 1994) substantiating our present finding of its significantly low level in TB patients with HIV coinfection. Increased susceptibility to TB was seen in HIV-infected individuals with low plasma concentrations of selenium (Shor-Posner et al., 2002) . The trace element appears to be important in reducing the virulence of HIV and slowing the progression of HIV-related disease (Rayman, 2000) . It is worth noting that, deficiencies in antioxidants during HIV infection were shown to induce chronic oxidative stress (Pace and Leaf, 1995) , which has been linked to apoptosis of T lymphocytes during HIV disease (Dobmeyer et al., 1997) and increased rates of HIV replication by activating the nuclear factor-kB (NF-kB) gene (Schreck et al., 1991) . Selenium supplementation stimulates glutathione peroxidase activity and reduces NF-kB activation in HIV-1-infected cell lines (Sappey et al., 1994) .
To our knowledge, this is the first study to demonstrate variation in serum levels of zinc, selenium and copper in HIV-infected adult TB patients before and after anti-TB chemotherapy. Interestingly, the levels of copper, selenium and copper/zinc ratio after treatment were within the range of healthy controls. This observation may be of potential importance because selenium deficiency increased mortality during HIV infection (Sauberlich and Page, 1997) , and selenium supplementation for HIV-infected subjects reduced their morbidity (Burbano et al., 2002) . Nevertheless, it is unknown whether selenium supplementation will reduce morbidity and mortality among HIV-infected adults with TB. On the other hand, in the TB patients without HIV coinfection, an increase in serum zinc and selenium, and a decrease in serum copper concentrations were observed after treatment. In line with this, a study in China also revealed an increase in serum copper after therapy (Yu, 1989) . Ciftci et al. (2003) observed a significant increase in serum zinc and a significant decrease in copper/zinc ratio in Turkish patients with pulmonary TB 2 months after anti-TB chemotherapy. Even though a full course anti-TB therapy requires 6 months of treatment, the serum level of selenium, zinc, copper and copper/zinc ratio, as observed in the first 2 months of treatment, may give an important clue in monitoring response to therapy.
It is interesting to note that an association between acutephase response to infection and alteration in dynamics of many trace elements, particularly iron, zinc and copper, has been recognized for many decades (Scrimshaw et al., 1968) . The fall in serum iron and zinc, and rise in serum copper, are brought about by changes in the concentration of specific tissue proteins such as C-reactive protein (CRP) that are controlled by cytokines (Tomkins, 2003) . Although, the changes are generally believed to be beneficial aspects of the early acute-phase response, the assessment of status for these elements is particularly difficult, since plasma concentration may bear little relationship to tissue status. Therefore, simultaneous assessment of acute-phase proteins, for example, serum CRP, together with trace elements and monitoring changes in concentrations, has been suggested as an important step in the interpretation of serum level of trace elements (Shenkin, 1995) . A limitation of this study was the failure to include parameters for the acute-phase response or inflammation (such as CRP) and markers for progression of HIV infection (CD4T cells count). Inclusion of such parameters may help to delineate whether the observed values of serum levels of trace elements in TB patients with or without HIV coinfection versus controls were due to the acute-phase response or due to micronutrient status, in future studies.
In conclusion, this study shows that the serum concentration of trace elements in patients with TB was altered. The low concentrations of zinc, iron and selenium could result from preceding deficiencies that enhanced susceptibility to infection, and/or from their high demands in overt TB. Further studies are required to establish the role of these low concentrations in host defense against TB, so that appropriate and beneficial strategies for micronutrient supplementation can be planned. In addition, the changes in serum trace elements during anti-TB chemotherapy might be used as a valuable parameter in assessing response to therapy.
